Dates: September 25, 2025
Location: Paris, France
Event Website: CRC Scientific Day 2025 – Centre de recherche des Cordeliers
Join Metabolon at CRC Scientific Day 2025
Metabolon is attending the 2025 CRC Scientific Day, an annual scientific symposium hosted by the Centre de Recherche des Cordeliers in Paris that brings together students, post‑docs and early-career researchers as well as globally recognized keynote speakers Centre de recherche des Cordeliers. This event gathers leading experts in oncology, immunology and metabolism research to explore cutting‑edge scientific findings and translational advances.
You will find Virginie Lambert and Alessandro Busetti at Metabolon’s table exhibition. Come by to learn more about how metabolomics is accelerating discovery in cancer metabolism and unlocking actionable biological insights across immuno‑metabolism and biomarker discovery.
Key Themes at CRC Scientific Day 2025
CRC Scientific Day 2025 will showcase innovative research and emerging technologies across key focus areas such as:
- Metabolism and Immunology
- Environment, exposome, and genome
- Therapeutic innovation and personalized medicine
- Ethics, research, and society
Metabolomics is a unifying thread across immunology, environment, therapy, and ethics. It shapes immune cell behavior, tumor microenvironments, and responses to treatment. Connects environmental exposures with genetic predisposition, enabling personalized medicine. It also highlights health disparities, raising ethical considerations in precision health plays a pivotal role in many of these themes by uncovering metabolic signatures that reflect tumor‑immune dynamics and by identifying actionable biomarkers to better stratify patients and tailor interventions.
The Role of Metabolomics in Cancer, Immunology & Metabolism
Unlike genomics or proteomics, which infer functional potential, metabolomics captures the end products of cellular activity—giving real‑time insight into physiological and pathophysiological states including tumor metabolism, immune activation, and treatment response.
Uniquely, metabolomics sits at the intersection of genetics, lifestyle, the environment, and microbiome influence, reflecting the cumulative impact of these factors on individual health. It bridges the gap between genotype and phenotype, accelerating translational research and making immuno‑oncology and metabolism research more predictive, preventive, and effective.
Find out more:
– Why Metabolomics – Metabolon
– Why Metabolomics: Your Guide to Metabolomics – Metabolon
CRC Scientific Day 2025 Featured Session
Featured Session: learn more about the impact of metabolomics in reshaping cancer therapy strategies
12:55 – 13:05 Alessandro Busetti (Metabolon) – “From Data to Discovery: Real-World Applications of Untargeted Metabolomics in Cancer”
Untargeted metabolomics offers a unique window into the biochemical underpinnings of health and disease, uncovering layers of insight beyond what is accessible through genomics or proteomics alone. This presentation will introduce Metabolon’s industry-leading platform and illustrate its value through two case studies in oncology. The first highlights how metabolomics enabled the identification of predictive biomarkers for therapeutic response, supporting patient stratification and precision medicine efforts. The second case examines how a specific genetic mutation conferred resistance to a chemotherapeutic agent in acute lymphoblastic leukemia (ALL), and how metabolomic profiling revealed the underlying metabolic mechanism, leading to a therapeutic opportunity. These examples demonstrate how a metabolomics-driven, multi-omics approach can unlock actionable insights and accelerate translational cancer research.
Why visiting Metabolon’s booth at CRC Scientific Day 2025
With 25 years of expertise, over 4,000 publications, more than 15,000 completed projects, and the world’s largest curated metabolite reference library (5,400+ level 1 & 2 annotated metabolites), Metabolon is the global leader in metabolomics.
We use high‑resolution mass spectrometry, stringent quality controls, and deep biochemical annotation to accurately identify and quantify metabolites across diverse sample types.
Our Integrated Bioinformatics Platform enables combining omics such as genomics, transcriptomics, and proteomics in one unified environment—with advanced stats, ML models and interactive visualization—for seamless translational research collaboration.
Don’t stay behind – incorporate high-quality metabolomics analysis in your project. Book a meeting with Virginie and Alessandro by filling the form on this page!
In the meantime, feel free to browse some helpful cancer, immunology & exposome resources:
- Cancer and Metabolism | Metabolon
- Metabolomics For Immuno-Oncology | Metabolon
- The Exposome: A New Frontier in Disease Research | Metabolon
Meet Metabolon’s Team at CRC Scientific Day 2025
Virginie Lambert, Sales & Business Development Director, France & Belgium. With over 15 years of experience in the Biotechnology and Life Sciences industry, will be your point of contact at Metabolon in France and Belgium. She will assist you in finding the best solutions and advancing in metabolomics thanks to her expertise in various omics. Her knowledge of academic research and R&D in the industry, will give you access to high quality services that meet the standards of your R&D projects. Virginie is based in the Rouen region, Normandy.
Alessandro Busetti, PhD, Field Metabolomic Scientist– Dr Busetti spent 10 years conducting research in academia, both as a Research Fellow at QUB and as a Research Associate at the University of Glasgow. His research focused on the discovery of marine-derived bioactives for biomedical applications and understanding the role of microbiomes in regulating host health. In 2016 he transitioned into industry and joined 4D Pharma PLC where he worked as the Senior Team Leader of the “Discovery-Micro” Department. There, he defined and implemented screening strategies to identify candidate LBP strains for several disease areas ranging from autoimmune diseases, solid tumors, neurodegenerative diseases, and more.
Let’s connect in Paris and discuss how metabolomics can support your immuno‑metabolism and biomarker discovery goals – book a meeting with Virginie and Alessandro using the form on this page.
